| 74.08 1.48 (2.04%) | 10-14 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 89.51  |
1-year : | 93.18 |
| Resists | First : | 76.63 |
Second : | 79.77 |
| Pivot price | 74.69 |
|||
| Supports | First : | 71.55 | Second : | 59.52 |
| MAs | MA(5) : | 73.96 |
MA(20) : | 75.26 |
| MA(100) : | 83.43 |
MA(250) : | 87.33 |
|
| MACD | MACD : | -1.6 |
Signal : | -1.6 |
| %K %D | K(14,3) : | 22.3 |
D(3) : | 25.1 |
| RSI | RSI(14): 42.3 |
|||
| 52-week | High : | 99.19 | Low : | 71.55 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ALC ] has closed above bottom band by 39.3%. Bollinger Bands are 24.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 74.31 - 74.59 | 74.59 - 74.92 |
| Low: | 71.87 - 72.18 | 72.18 - 72.53 |
| Close: | 73.5 - 74 | 74 - 74.57 |
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
Tue, 14 Oct 2025
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Alcon (ALC) - The Globe and Mail
Mon, 13 Oct 2025
BTIG Maintains Alcon (ALC) Buy Recommendation - Nasdaq
Mon, 13 Oct 2025
Barclays Initiates Coverage on Alcon (ALC) with Equal-Weight Rat - GuruFocus
Mon, 13 Oct 2025
Alcon Inc. (ALC) Investor Outlook: Eyeing A 35% Upside With Strong Buy Ratings - DirectorsTalk Interviews
Fri, 10 Oct 2025
Investor Group Opposes Alcon's Acquisition of STAAR Surgical (AL - GuruFocus
Mon, 29 Sep 2025
Alcon Inc. (ALC) Stock Analysis: Eyeing A 32% Upside With Strong Buy Ratings - DirectorsTalk Interviews
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 494 (M) |
| Shares Float | 493 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 70.1 (%) |
| Shares Short | 5,410 (K) |
| Shares Short P.Month | 5,400 (K) |
| EPS | 2.16 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 44.72 |
| Profit Margin | 10.6 % |
| Operating Margin | 11.1 % |
| Return on Assets (ttm) | 2.6 % |
| Return on Equity (ttm) | 4.9 % |
| Qtrly Rev. Growth | 4 % |
| Gross Profit (p.s.) | 11.26 |
| Sales Per Share | 20.26 |
| EBITDA (p.s.) | 4.73 |
| Qtrly Earnings Growth | -22.3 % |
| Operating Cash Flow | 2,100 (M) |
| Levered Free Cash Flow | 1,140 (M) |
| PE Ratio | 34.29 |
| PEG Ratio | 0 |
| Price to Book value | 1.65 |
| Price to Sales | 3.65 |
| Price to Cash Flow | 17.44 |
| Dividend | 0.33 |
| Forward Dividend | 0 |
| Dividend Yield | 0.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|